Related Experiment Videos

IGF-1 inhibits the mitochondrial apoptosis program in mesangial cells exposed to high glucose

Barinder P S Kang1, Arunas Urbonas, Andrew Baddoo

  • 1Division of Nephrology, Department of Medicine, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, NJ 07103, USA.

Insights

Insulin-like growth factor-1 receptor (IGF-1R) activation protects kidney mesangial cells from high glucose-induced apoptosis. This survival pathway involves Akt/PKB and ERK signaling, preserving mitochondrial function and inhibiting cell death.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Renal Physiology

Background:

  • Hyperglycemia induces oxidative stress and mitochondrial apoptosis.
  • Insulin-like growth factor-1 receptor (IGF-1R) signaling is crucial for cell survival.

Purpose of the Study:

  • To investigate the protective role of IGF-1R activation against hyperglycemia-induced apoptosis in mesangial cells.
  • To elucidate the signaling pathways involved in IGF-1R-mediated cytoprotection.

Main Methods:

  • Ligand activation of IGF-1R in human and murine mesangial cells.
  • Assessment of apoptosis, reactive oxygen species generation, and mitochondrial potential.
  • Analysis of key apoptosis regulatory proteins (Bcl-2 family) and kinase activity (Akt/PKB, ERK).

Main Results:

  • IGF-1R activation protected mesangial cells from glycol-oxidant-induced apoptosis.
  • The protective effect was dependent on Akt/PKB and ERK signaling.
  • IGF-1 treatment preserved mitochondrial function and inhibited apoptosis by modulating Bcl-2 family proteins, including Bad phosphorylation.
  • ERK signaling directly phosphorylated mitochondrial Bad, linking surface IGF-1R to mitochondrial survival.

Conclusions:

  • IGF-1R activation initiates a survival program in mesangial cells under high glucose conditions.
  • This program involves Akt/PKB and ERK pathways, leading to mitochondrial protection and inhibition of apoptosis.
  • IGF-1R signaling represents a potential therapeutic target for diabetic nephropathy complications.

Related Concept Videos